IGC Pharma (IGC) Return on Equity (2016 - 2025)
Historic Return on Equity for Pharma (IGC) over the last 16 years, with Q3 2025 value amounting to 0.91%.
- Pharma's Return on Equity rose 7400.0% to 0.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91%, marking a year-over-year increase of 7400.0%. This contributed to the annual value of 1.04% for FY2025, which is 1300.0% up from last year.
- Latest data reveals that Pharma reported Return on Equity of 0.91% as of Q3 2025, which was up 7400.0% from 1.02% recorded in Q2 2025.
- In the past 5 years, Pharma's Return on Equity registered a high of 0.27% during Q2 2021, and its lowest value of 1.75% during Q2 2024.
- Its 5-year average for Return on Equity is 0.88%, with a median of 0.77% in 2023.
- In the last 5 years, Pharma's Return on Equity plummeted by -9800bps in 2024 and then soared by 7400bps in 2025.
- Pharma's Return on Equity (Quarter) stood at 0.38% in 2021, then plummeted by -93bps to 0.73% in 2022, then plummeted by -68bps to 1.22% in 2023, then dropped by -6bps to 1.29% in 2024, then grew by 30bps to 0.91% in 2025.
- Its Return on Equity stands at 0.91% for Q3 2025, versus 1.02% for Q2 2025 and 1.13% for Q1 2025.